BioOhio Board of Trustees

BioOhio is proud to have a board comprised of some of the most influential leaders in Ohio’s bioscience community. From all corners of the state, and representing many business elements within the life cycle of a company, this leadership assists BioOhio accomplish its mission.

Geoff Morgan, BioOhio Board Chair, Vice President & General Manager, Quidel

Geoff has been with Quidel/Diagnostic Hybrids since 2003, serving as Vice President and Chief Financial Officer, and most recently as Vice President and General Manager. Prior to Quidel, Geoff was with Blue Chip Broadcasting and PricewaterhouseCoopers, both in the Cincinnati area, for 15 years. Geoff is a graduate of Miami University and University of Tulsa (Oklahoma).

Joseph E. Berger, Senior Vice President, Commercial Business, Battelle

Joe Berger is Senior Vice President, Commercial Business in Battelle’s Contract Research Division. During his decade at Battelle, Joe has also served as the Vice President and General Manager of the Health and  Consumer Products Business Unit, as well as roles in Sales, Business Development and Operations Management. Joe’s career has focused on sales, marketing, sales management and general management of highly technical products and services. His industry experience includes working with companies in the specialty chemicals, food ingredients, semiconductor capital equipment and industrial equipment markets. He has worked for both very large and start-up companies and has spent significant time with customers outside of the U.S., mostly in Asia and Western Europe.

Diane Berry, PhD, Vice President, Global Policy, Government & Patient Affairs, Sarepta Therapeutics

Diane joined Sarepta Therapeutics in December 2011 and serves as Vice President, Global Policy, Government & Patient Affairs. She engages policymakers at the federal, state, and local levels, as well as patient advocacy organizations, to advance critical policies related to newborn screening, regulatory policy, and reimbursement and access with a goal of expediting development and patient access to genetic-based therapies for rare diseases. Previously, Dr. Berry served in leadership roles for the federal government, across the legislative and executive branches, overseeing and implementing science and technology and public health activities. She served as a Subcommittee Staff Director and Senior Professional Staff Member for the U.S. House of Representatives Committee on Homeland Security and as Chief Scientist and Senior Biodefense Advisor at the Department of Homeland Security in the Office of Health Affairs. Dr. Berry was also a Senior Science Advisor at McKenna, Long, and Aldridge and a Science and Technology Policy Advisor and Fellow within the Department of Defense through the American Association for the Advancement of Science. She earned her Ph.D. in chemical engineering from Northwestern University and received her B.S. and M.S. in chemical/biochemical engineering from Tufts University.

Shauna R. Brummet, Ph.D., President & CEO, BioHio Research Park, an Affiliate of The Ohio State University, College of Food, Agricultural and Environmental Sciences

Dr. Brummet has broad experience in life science research and product development, startup and global companies, innovation and technology commercialization, technology-based economic development, and open innovation. Shauna is highly collaborative and connected in the innovation ecosystem. Development and commercialization of new technology, creation of teams and organizations, public-private partnerships, entrepreneurial coaching, innovation and entrepreneurship in higher education and open innovation are key areas of her expertise. Shauna is a graduate of Purdue University (BS in Microbiology), University of Akron (MS, PhD in Analytical and Biochemistry), and post-doctoral work in molecular biology at The Ohio State University Ohio Agricultural Research & Development Center. Previous employers include United States Biochemical, Amersham Life Sciences, Edison Biotechnology Center/BioOhio, NineSigma, and Fluence Therapeutics (founder).

Erica Conroy, Ph.D., VP, Operations, CoverMyMeds

Before coming onboard with CoverMyMeds, Erica spent five years at Vertex Pharmaceuticals as a medicinal chemist. Erica completed her Bachelor of Science in Biochemistry from California Polytechnic State University, her Ph.D. in Organic Chemistry from The Ohio State University and continued on to achieve a Post-doctorate in Organic Chemistry from The Scripps Research Institute. As VP of Operations at CoverMyMeds, Erica is responsible for overall leadership of operations, analytics, forecasting, recruiting and training.

Lisa Dankovich, Director of University External Relations, Miami University

Lisa Dankovich is the director of university external relations at Miami University. Through her work with the Cincinnati Business Committee; the Cincinnati Regional Business Committee; the Cincinnati USA Regional Chamber; REDI Cincinnati; Cintrifuse; and CincyTech she’s often called the university’s “Chief Cincinnati Engagement Officer.” She plays an instrumental role in the research and innovation office while leveraging academics & businesses to collaborate on technology commercialization for the Air Force Research Lab and Wright Brother’s Institute. She’s on REDI’s Regional Economic Development Strategy Steering Committee and is a member of the Cincinnati Chamber’s Leadership Cincinnati (Class 43). She’s also a member of Miami University’s Athletic Hall of Fame. Lisa earned a bachelor’s degree from Miami University and a master’s degree from Indiana University.

Michael Gaul, Group Vice President, Manufacturing and Design Services, Sparton Corporation

Michael Gaul has been with Sparton since 2011. Prior to joining Sparton, he was COO at SynCardia Systems, which manufactures the Jarvik Artificial Heart. He has held senior leadership positions in organizations in highly regulated industries including healthcare, military, aerospace and public safety. He has experience with a broad range of products and services including medical devices, diagnostics and reagents, complex electro-mechanical instrumentation, automation, printed circuit board assembly, RF equipment and contract manufacturing and design services. His expertise includes operational excellence, sales and marketing effectiveness, and supply chain, financial and general management. Michael earned his BS in Business Administration from Delaware Valley College and his MBA from Florida Institute of Technology.

Stephanie Harrington, MS, CEO, Matrix Medical Devices

Matrix Medical Device founder and visionary, Stephanie Harrington has over 20 years of management experience in the medical device industry, including regulatory affairs, quality system compliance, clinical studies, product development, and commercialization. Guiding startups and established companies alike through new product development and regulatory affairs management is her current mission. Previously, Stephanie served as Chief Operating Officer of Frantz Medical Development, responsible for new product development, manufacturing, and corporate regulatory and quality affairs. Stephanie also served as Vice President and Chief Regulatory Officer at Imalux, establishing the company’s quality system, 510(k) clearances and clinical studies. Prior to Imalux, she was Director, Research and Development at STERIS, responsible for product development of medical device reprocessing systems. Stephanie earned a Masters in Chemical Engineering from Stanford University and holds a BS in Chemical Engineering from the University of Maryland.

Jason Heikenfeld, Ph.D., Professor and Assistant Vice President for Commercialization, University of Cincinnati

In his current role at the University of Cincinnati, Jason leads the institution’s office supporting patenting, licensing, and startup efforts. He also directs the Novel Devices Laboratory, which has established highly-focused international leadership roles in emergent technological paradigms that include electrowetting, electronic paper, and most recently sweat biosensing technology. In the first decade of his career, Jason already accumulated the most patents and licensees of any faculty member in the history of the University of Cincinnati. He is a serial entrepreneur, and his most recent company, Eccrine Systems, has been recognized as a top 50 global startup by Bloomberg/Quid. In his service roles to the University, Jason has led the creation of programs and coursework that foster innovation, entrepreneurship, and an understanding of the profound impact that technology has on society.

Mike Hooven, President and CEO, Enable Injections

Mike has extensive experience in the medical device industry in a broad variety of technical and clinical areas. He is the founder of five medical device companies and holds over 85 issued and pending US patents. Enable Injections is a start-up company focusing on painless injections for vaccines and other drugs. Enable Medical Technologies is a start-up company focusing on opportunities in minimally invasive procedures. Mike is the founder, and a Director of AtriCure, Inc., a medical device company that manufactures and sells surgical devices designed to create precise lesions in soft tissue. He was Director of Product Development at Ethicon Endo-Surgery from 1988 to 1994, and held engineering positions at Siemens/Pacesetter from 1986 to 1988, and at Cordis Corporation from 1981 to 1986. Mike earned a Bachelor of Science in Physics and a Master of Science in Mechanical Engineering from the University of Michigan.

Peter G. Kleinhenz, BioOhio Past Board Chair, Managing Director, Woodhall Consulting

Peter Kleinhenz is a senior executive in life science and technology businesses with over 25 years as experience as an operating executive, entrepreneur, consultant, and investor. Throughout his career Peter has driven results through his skills in strategic and operational planning, product planning and development, operations, finance and administration. He has worked across the spectrum of companies from start-ups to late stage technology-based enterprises. Prior to Woodhall Consulting, Peter worked with Myonexus Therapeutics, CID, Fletcher Spaght, Battelle, Progenics, and Neoprobe. Peter received an MBA from Case Western Reserve University, his undergraduate degree from Loyola University of Chicago, and is a Certified Public Accountant licensed in Ohio.

Michelle Leonard, Vice President Global Human Resources, NAMSA

Michelle Leonard joined North American Science Associates (NAMSA) in August 2015 as Director Total Rewards and was named VP, Global Human Resources in April 2019. Michelle is a solution-oriented, forward thinking leader that is committed to collaboration, transparency and solutions that are meaningful to the company and its employees. During her leadership at NAMSA the company has implemented several strategic initiatives to support a total wellness strategy, a global compensation structure and a global HRIS system. Michelle has held progressively responsible positions in Human Resources management within Holcim (US) Inc., Aggregate Industries US, Holcim (Canada) Inc., and HCR Manorcare. She has her Bachelor of Science in Human Resources Management and Services from Bowling Green State University and a MBA in Finance from The University of Toledo.

John F. Lewis, Jr., President and CEO, BioOhio

John Lewis, a 4th generation Ohioan, is the President and CEO of BioOhio, Ohio’s bioscience membership organization. He is a licensed attorney with experience in international business, venture capital investments and economic development. He was a founding partner of the First Fifty Fund and Ohio TechAngel Fund. John has more than 18 years international experience, lived in Jamaica, Korea and China, the latter two with Perkin Elmer, while traveling to more than 42 others. John is a graduate of Miami University (Ohio) and Capital University Law School.

Peter Mohler, Ph.D., Senior Associate Dean for Research, Director, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University

Peter Mohler joined The Ohio State University in 2011 as the Director of the Dorothy M. Davis Heart and Lung Research Institute. Prior to this role, Mohler served as Deputy Director of the Diabetes Center and Distinguished Associated Professor of Cardiovascular Medicine at the University of Iowa. He completed his undergraduate work at Wake Forest University, received his PhD from the University of North Carolina, did a Post-doctoral fellowship in the Howard Hughes Medical Institute at Duke University, and held his first faculty appointment at the Vanderbilt University Medical Center. Mohler currently holds multiple NIH extramural grants, is the recipient of honors and awards for his work, serves on national scientific review boards for the US, UK, Italy, France, Belgium, Austria, and Israel, and is on the editorial board for seven journals.

Kristen Parr, VP of Operations Strategy, Alkermes, Inc.

Kristen Parr has been employed at Alkermes for more than 20 years.  Kristen has held many positions at Alkermes and has a broad understanding of the pharmaceutical industry; specifically in Operations (manufacturing and packaging of both sterile injectable and solid oral dosage products), Supply Chain, Quality, Project Management, Process Development and new drug filings and launches.  Prior to her current position, Kristen was the General Manager of the Wilmington Ohio manufacturing facility with a staff of over 500 employees. She currently leads development and execution of Operations Strategy for Alkermes which includes EHSS, Quality, Supply Chain, and the manufacturing teams. Kristen obtained her B.A. in Chemistry from Indiana University in Bloomington, IN.

John P. Pigott, MD, FACS, Chief Innovations Officer/ Strategic Business Development ProMedica Healthcare System, Founder & Chief Science Officer, VentureMed Group

Dr. Pigott is a recognized leader in medical innovations and vascular surgery. He is founder and president of VentureMed Group, a medical device company involved in the treatment of peripheral artery disease and a founding member of Vascular Innovations, a company devoted to novel technologies for aortic aneurysms. A member of Cleveland Clinic Innovations Commercialization Advisory Board, Dr. Pigott holds his own patents for devices involving aortic aneurysm and peripheral artery technologies. He serves as a consultant to numerous multinational medical device companies and conducts national and regional new device training programs. Dr. Pigott was an early proponent of minimally invasive endovascular treatment for abdominal aortic aneurysms, carotid artery and peripheral artery disease and was a principal investigator for national clinical trials studying these techniques. As a board-certified vascular surgeon at Jobst Vascular Institute (JVI) and ProMedica Toledo Hospital, Dr. Pigott serves as a faculty member of the ACGME-accredited Jobst Vascular Fellowship Program. Dr. Pigott received his medical degree from the Medical College of Ohio, completed his residency at Akron City Hospital, and is fellowship-trained by Mayo Clinic.

Aaron Pitts, Managing Director, Biohealth and Agribusiness, Food Processing, JobsOhio

As managing director, Aaron Pitts has responsibility for defining and executing growth strategies for Ohio’s Biohealth and Agribusiness and Food Processing industries. Aaron joined JobsOhio in 2013 after spending the past 12 years at Cardinal Health where he focused on strategy, business development, and general management roles for the $100b global healthcare services company. Previously, Aaron held management consulting positions with Ernst & Young and PricewaterhouseCoopers where he executed operations strategy initiatives across consumer packaged goods, food processing, healthcare, and financial services sectors. Education: University of Minnesota, MBA; The Ohio State University, BSBA.

Mike Sieron, Medical Device Professional

Mr. Sieron has worked for a number of both publicly traded and private companies in his career including DG Medical, AcuTemp, Thermo Electron, the Swedish company Sunds Defibrator, and most recently with P&C Pharma as President & COO. Mr. Sieron’s professional accomplishments include sitting on various Boards of Directors in fiduciary and advisory capacities, successfully executing several acquisitions, setting up various global sales networks and being awarded numerous patents. Mr. Sieron holds a Bachelor of Science degree in Mechanical Engineering and a minor in Business from the University of Cincinnati. He has continued his education with executive education courses in finance, management, and other disciplines from The Kellogg School of Management at Northwestern University and Xavier University.

Jon J. Snyder, Founder, Chief Business Officer, Neuros Medical

Jon Snyder is the Founding President and CEO of Neuros Medical, Inc., a Cleveland, Ohio based neuromodulation company focused on developing proprietary therapies for unmet needs to patients worldwide. He holds over 20 years of global management experience in biomedical and healthcare sales, marketing, and operations with significant experience in bringing new products into the marketplace. His background covers business development, product development, market management, sales management, venture capital investment, and fundraising at start-up and Fortune 500 (Top 20) companies including Cyberonics, Cardinal Health, Imalux, and STERIS. Snyder has a B.S. from Ohio University.

Charles Steiner, Director, Business & Product Development | Innovations, Cleveland Clinic

Charles Steiner has over 25 years of experience in medical technology development. Prior to joining CCI, Charles was a product development engineer for the Center for Neurological Restoration and a business and technology developer for the Center for Minimally Invasive Surgery at Cleveland Clinic. His contributions have been in the field of surgical navigation for cranial and spinal indications, neuromodulation for movement and cognitive indications as well as neuromodulation for headache and autonomic indications. Charles received his BS in chemistry and computer science from Case Western Reserve University.

Stacy Strauss, Director, Ohio University Innovation Center

Stacy Strauss joined the Innovation Center as the Associate Director in August 2014 and was promoted to Director in October 2016. At the Innovation Center, Ms. Strauss oversees the staff, makes connections for clients, oversees facility management, fundraising efforts, budget analysis, grant writing, and other Innovation Center operations. She was instrumental in securing a $2 million dollar grant from the Appalachian Regional Commission in 2016. Ms. Strauss joined the Innovation Center from Hocking College, where she served in a dual role as a Student Affairs Coordinator and Career Services Director from April 2013 through August 2014. Ms. Strauss holds a bachelor’s degree in history from Kenyon College and a master’s degree in education from Ohio State University. She also holds a Business Incubator Management certificate from the International Business Innovation Association.

Shari Strunk, SPHR, Associate Director, Human Resources, Allergan

Shari is an Associate Director, Human Resources at Allergan Pharmaceuticals. In her role, she supports key manufacturing operations of the business which include Allergan’s solid oral dose portfolio located in Cincinnati, Allergan’s Skin Medica® manufacturing in Houston and two sites in California which manufacture the drug substance for BOTOX®. Shari core values are authenticity, collaboration and making an impact. Shari has her BA in Psychology and Sociology from Miami University in Oxford, OH. She also has an SPHR certification from the Human Resource Certification Institute. She has won various awards during her time at Allergan, including the CEO BOLD Award for her work on operational excellence programs and is part of the site leadership team in Cincinnati who earned the Plant of the Year award in 2017 and 2018.

Bert G. Wickey, Director, Healthcare Policy and Advocacy – Strategic Customer Group, Johnson & Johnson

Bert Wickey is a Healthcare Policy & Advocacy Director representing the Janssen Pharmaceutical Inc. sector for Johnson & Johnson in Ohio & Kentucky. Janssen currently promotes 22 products in six therapeutic areas including Cardiovascular & Metabolism, Immunology, Infectious Diseases, Neuroscience and Oncology. In his 30th year at Johnson and Johnson, he has experience in various roles including sales, sales management, contracting with commercial & government payers, and policy & advocacy. Over the past 10 years, his role has focused on engaging provider and patient advocacy organizations at the state & national level regarding appropriate access to treatment and preserving the provider/patient decision making process. Bert is a graduate of California State University – Sacramento, CA and has resided in Medina, OH for the past 22 years.